Postal survey of physicians and laboratories: practices and perceptions of molecular oncology testing
about
Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatmentKnowledge of genetic testing for hereditary kidney cancer in Canada is lacking: The results of the Canadian national hereditary kidney cancer needs assessment survey.Access to genetic testing and genetic counseling in vulnerable populations: the d/Deaf and hard of hearing populationPersonalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicineReal-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States.Barriers to the use of personalized medicine in breast cancer.Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.Diagnosis of oligodendroglioma: molecular and classical histological assessment in the twenty-first century.Keeping up with the times: revising the dermatology residency curriculum in the era of molecular diagnostics and personalized medicine.Development of a curriculum in molecular diagnostics, genomics and personalized medicine for dermatology trainees.Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach.Medical Oncologists' Experiences in Using Genomic Testing for Lung and Colorectal Cancer Care.A call to action: dermatopathology in the age of molecular testing--education in molecular diagnostics, genomics and personalized medicine.Advanced cancer patients' attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study.Interactive or static reports to guide clinical interpretation of cancer genomics.Barriers for integrating personalized medicine into clinical practice: a qualitative analysis.
P2860
Q33763903-144F3692-5EA2-4375-A2FB-519CF62EDCB3Q34602163-6C26291E-8DB5-4597-BD65-54858D7D2E4EQ35263880-78F182E1-4F7D-4C21-993A-C960743DF4F9Q35319902-1E7D8FDA-AC0F-4A9E-BF2E-B98CEF57159FQ36050294-530397E3-011C-4A25-9A88-77F0E586BBEFQ36095254-B6EB49EE-EBA6-4B75-80E6-B0D922749034Q37508612-DAE0DE01-AE60-4DE5-898F-8D9BB212008BQ38035066-57420BD9-10B0-4DAA-9FB8-74AB2C120C23Q38248176-C8BEACBF-143C-42CE-A0B6-9F9072962B30Q38872266-B1857528-AA5A-4033-A4E1-7B66A23597D8Q39343068-1EBF0DD0-598B-4099-90EE-428BFB1D740BQ43994049-EE8BEACF-A326-47CF-85BF-A79B6820C792Q44280192-676C3724-BE21-457D-B698-0F6816F9B5EAQ46652808-8E45652B-CFC7-449A-ACD8-B4F01EA6F51EQ47190133-A6AC7627-FAA7-4315-9B21-F49201660EF8Q53105237-713032C5-686D-4A44-925D-060806199E64
P2860
Postal survey of physicians and laboratories: practices and perceptions of molecular oncology testing
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Postal survey of physicians an ...... of molecular oncology testing
@ast
Postal survey of physicians an ...... of molecular oncology testing
@en
type
label
Postal survey of physicians an ...... of molecular oncology testing
@ast
Postal survey of physicians an ...... of molecular oncology testing
@en
prefLabel
Postal survey of physicians an ...... of molecular oncology testing
@ast
Postal survey of physicians an ...... of molecular oncology testing
@en
P2093
P2860
P356
P1476
Postal survey of physicians an ...... of molecular oncology testing
@en
P2093
Catherine Ahern
Paul Krueger
Robert J Christensen
Ronald F Carter
P2860
P2888
P356
10.1186/1472-6963-9-131
P577
2009-07-30T00:00:00Z
P5875
P6179
1011359469